MiNK Therapeutics, Inc. - Stock (INKT)

CUSIP: 603693102

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Stock
Total 13F shares
355,276
Share change
-422,402
Total reported value
$501,000
Price per share
$1.41
Number of holders
5
Value change
-$933,391
Number of buys
1
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 603693102?
CUSIP 603693102 identifies INKT - MiNK Therapeutics, Inc. - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MiNK Therapeutics, Inc. - Stock (INKT) as of Q2 2022

As of 30 Jun 2022, MiNK Therapeutics, Inc. - Stock (INKT) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 355,276 shares. The largest 5 holders included Artal Group S.A., BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., and FMR LLC. This page lists 5 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.